Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas
2005

DNA Vaccine Protects Hamsters from Oral Cancer

Sample size: 38 publication 10 minutes Evidence: moderate

Author Information

Author(s): Berta G N, Mognetti B, Spadaro M, Trione E, Amici A, Forni G, Di Carlo F, Cavallo F

Primary Institution: Department of Clinical and Biological Sciences, Ospedale San Luigi Gonzaga, University of Turin

Hypothesis

Can a DNA vaccine effectively prevent oral squamous cell carcinoma in Syrian hamsters?

Conclusion

The study found that a DNA vaccine significantly reduced the incidence of cancerous lesions in vaccinated hamsters compared to controls.

Supporting Evidence

  • Vaccinated hamsters had a lower incidence of cancerous lesions compared to control hamsters.
  • Vaccinated hamsters showed a stronger immune response with higher antibody levels.
  • Electroporation helped the DNA vaccine work better in the hamsters.

Takeaway

Researchers gave hamsters a special vaccine to help them fight off mouth cancer, and it worked really well!

Methodology

The study involved vaccinating hamsters with DNA plasmids and then challenging them with cancer cells to observe the immune response.

Limitations

The study was conducted in a specific animal model, which may not fully represent human responses.

Participant Demographics

38 male Syrian hamsters aged 4–6 weeks.

Statistical Information

P-Value

0.0027

Statistical Significance

p<0.0027

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602853

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication